Recent

% | $
Quotes you view appear here for quick access.

Novavax, Inc. Message Board

  • smartdoc67 smartdoc67 May 21, 2014 10:25 AM Flag

    Saudi interaction.

    Meanwhile, Barclay Phillips, senior vice president, chief financial officer and treasurer at Novavax, a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases, informed Saudi Gazette that the company has not yet sent any experts to Saudi Arabia, “but would consider doing so based on interactions with Saudi health authorities.”

    He said traditional vaccine development and approval processes would require many years of additional product development work, including clinical trials to prove the safety and efficacy of a vaccine prior to formal regulatory approval.

    Asked if they were contacted by Saudi Ministry of Health about developing a vaccine for MERS, he said: “We are not in a position to publicly discuss any formal contact with the Saudi Ministry of Health or any other interested governmental agency. Novavax has and will make itself available, and is open to discussions, with interested parties.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NVAX
7.01-0.20(-2.77%)3:36 PMEDT